CytoSinct™ CD56 Nanobeads, human

CytoSinct CD56 Nanobeads, human is used for in vitro enrichment of CD56+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products, or single-cell suspension based on the surface expression of human CD56.

Price	$180.00
Cat. No.	L00903-0.5
Size	500 μl 1 ml Buy in bulk
Quantity
TAT


Ask us a question

Overview Properties Bottom Notes

Overview

Product Description

CytoSinct CD56 Nanobeads, human is used for in vitro enrichment of CD56⁺ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products, or single-cell suspension based on the surface expression of human CD56.
To begin the isolation, Nanobeads are added to the cells. The cells/beads mixed suspension is loaded onto a CytoSinct column placed in the CytoSinct magnet, or other compatible columns with a magnet.
The CD56⁺ cells labeled with Nanobeads are retained within the column and unlabelled cells (CD56^- cells) are flushed out during the wash step. After removing the column from the magnetic field, the retained CD56⁺ cells can be eluted as the positively selected cell fraction.

Back

Properties

Format

Supplied in phosphate-buffered saline (PBS), containing Human Serum Albumin (HSA) and Poloxamer 188.

Components

1 mL or 0.5 mL CytoSinct CD56 Nanobeads, human
Nanobeads conjugated to monoclonal anti-human CD56 antibodies (isotype: mouse IgG1).

Volume

Cat. No.	Size	Capacity
L00903-0.5	500 µL	Up to 5×10⁸ total cells
L00903-1	1 mL	Up to 1×10⁹total cells

Storage & Stability

Store at 2 - 8 °C. Do not freeze.

Back

CD56⁺ cells were enriched from human PBMCs. CD56⁺ cells were stained with anti-CD56 (clone: HCD56) PE and gated on Live/hCD45⁺ cells. »

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

Citations

1. Xinhui Hui, et al. GPR132 regulates the function of NK cells through the Gαs/CSK/ZAP70/NF-κB signaling pathway as a potential immune checkpoint. Sci Adv. (2025-03)